BruceAnthonyWernessMD

PubMed

• 2 citations
  Pilot study to evaluate tools to collect pathologist annotations for validating machine learning algorithms.
  Katherine Elfer, Sarah Dudgeon, Victor Garcia, Kim Blenman, Evangelos Hytopoulos, Si Wen, Xiaoxian Li, Amy Ly, Bruce Werness, Manasi S Sheth, Mohamed Amgad, Rajarsi Gu...> ;Journal of Medical Imaging. 2022 Jul 1
• 3 citations
  Development of Training Materials for Pathologists to Provide Machine Learning Validation Data of Tumor-Infiltrating Lymphocytes in Breast Cancer.
  Victor Garcia, Katherine Elfer, Dieter J E Peeters, Anna Ehinger, Bruce Werness, Amy Ly, Xiaoxian Li, Matthew G Hanna, Kim R M Blenman, Roberto Salgado, Brandon D Gallas> ;Cancers. 2022 May 17
• 15 citations
  A pathologist-annotated dataset for validating artificial intelligence: A project description and pilot study
  , , , , , , , , , , , , , , , , , , , , , > ;Journal of Pathology Informatics. 2021 Jan 1
• 82 citations
  Mucinous borderline ovarian tumors: Points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior
  Brigitte M. Ronnett, Andre Kajdacsy-Balla, C. Blake Gilks, Maria J. Merino, Elvio G. Silva, Bruce A. Werness, Robert H. Young> ;Human Pathology. 2004 Aug 1
• 58 citations
  Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry
  Bruce A. Werness, Susan J. Ramus, Richard A. DiCioccio, Alice S. Whittemore, Kim Garlinghouse-Jones, Ingrid Oakley-Girvan, Yoshiaki Tsukada, Patricia Harrington, Simon...> ;International Journal of Gynecological Pathology. 2004 Jan 1
• 32 citations
  BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases.
  Susan J. Ramus, Paul D.P. Pharoah, Patricia Harrington, Carole Pye, Bruce A. Werness, L.G. Bobrow, Ayse Ayhan, Dagan Wells, Ami Fishman, Martin Gore, Richard A. DiCioc...> ;Cancer Research. 2003 Jan 15
• 2 citations
  Endometrial carcinoma cells are nonpermissive for CD44-erbB2 interactions.
  Manja Wobus, Robin Kuns, Irene Sheyn, Bruce A. Werness, Nader Husseinzadeh, Bernard S. Aron, Larry S. Sherman> ;Applied Immunohistochemistry & Molecular Morphology. 2002 Sep 1
• Transitional cell ovarian carcinoma in a BRCA1 mutation carrier.
  Bruce A. Werness, Richard A. DiCioccio> ;Obstetrics and Gynecology. 2002 Aug 1
• 22 citations
  Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas.
  Alaa M Afify, Amy W. Ferguson, Rosa M. Davila, Bruce A. Werness> ;Applied Immunohistochemistry & Molecular Morphology. 2001 Dec 1
• 19 citations
  CD44 mediates constitutive type I receptor signaling in cervical carcinoma cells.
  Manja Wobus, Robin Kuns, Claudia Wolf, Lars Christian Horn, U Köhler, Irena Sheyn, Bruce A. Werness, Larry S. Sherman> ;Gynecologic Oncology. 2001 Nov 1
• 28 citations
  Familial Ovarian Cancer and Early Ovarian Cancer: Biologic, Pathologic, and Clinical Features
  Bruce A. Werness, Gamal H. Eltabbakh> ;International Journal of Gynecological Pathology. 2001 Jan 1
• 1 citations
  Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum.
  Bruce A. Werness> ;Human Pathology. 2000 Dec 1
• 49 citations
  Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations
  Bruce A. Werness, Susan J. Ramus, Alice S. Whittemore, Kim Garlinghouse-Jones, Ingrid Oakley-Girvan, Richard A. DiCioccio, Yoshiaki Tsukada, Bruce A.J. Ponder, M.Steve...> ;Human Pathology. 2000 Nov 1
• 9 citations
  Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation.
  Bruce A. Werness, Susan J. Ramus, Alice S. Whittemore, Kim Garlinghouse-Jones, Ingrid Oakley-Girvan, Richard A. DiCioccio, Yoshiaki Tsukada, Bruce A.J. Ponder, M.Steve...> ;International Journal of Gynecological Pathology. 2000 Oct 1
• 21 citations
  Comparative Study of Ovarian Cancer Histopathology by Registry Pathologists and Referral Pathologists: A Study by the Gilda Radner Familial Ovarian Cancer Registry
  M.Steven Piver, Yoshiaki Tsukada, Bruce A. Werness, Richard A. DiCioccio, Alice S. Whittemore, Bruce A.J. Ponder> ;Gynecologic Oncology. 2000 Aug 1
• 49 citations
  Ovarian Carcinoma In Situ With Germline BRCA1 Mutation and Loss of Heterozygosity at BRCA1 and TP53
  Bruce A. Werness, Pankhuri Parvatiyar, Susan J. Ramus, Alice S. Whittemore, Kim Garlinghouse-Jones, Ingrid Oakley-Girvan, Richard A. DiCioccio, Jonathan S. Wiest, Yosh...> ;Journal of the National Cancer Institute. 2000 Jul 5
• 52 citations
  Malignant peripheral nerve sheath tumors of the head and neck: analysis of prognostic factors.
  Thom R. Loree, James H. North, Bruce A. Werness, Rina Nangia, Alan P. Mullins, Wesley L. Hicks> ;Otolaryngology--Head and Neck Surgery. 2000 May 1
• 1 citations
  Ovarian dysplasia identified by cul-de-sac aspiration: a reexamination of previously reported cases.
  Bruce A. Werness, Gamal H. Eltabbakh> ;International Journal of Gynecological Pathology. 2000 Apr 1
• 34 citations
  Prognostic Significance of p53 and p21waf1/cip1 Immunoreactivity in Epithelial Cancers of the Ovary
  Bruce A. Werness, A N Freedman, M S Piver, M Romero-Gutierrez, E Petrow> ;Gynecologic Oncology. 1999 Dec 1
• 15 citations
  p53, c-erbB, and Ki-67 expression in ovaries removed prophylactically from women with a family history of ovarian cancer.
  Bruce A. Werness, Alaa M Afify, Gamal H. Eltabbakh, K Huelsman, M S Piver, J M Paterson> ;International Journal of Gynecological Pathology. 1999 Oct 1
• 23 citations
  Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors.
  H. A. Tworek, Ruoqi Peng, Sean Fetzer, Bruce A. Werness, M.Steven Piver, Howard J. Allen, Richard A. DiCioccio> ;Cancer Genetics and Cytogenetics. 1999 Jul 15
• 30 citations
  HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma
  Alaa M Afify, Bruce A. Werness, Hon Fong L. Mark> ;Experimental and Molecular Pathology. 1999 Jun 1
• 47 citations
  Expression of the Hyaluronan Receptor, CD44S, in Epithelial Ovarian Cancer Is an Independent Predictor of Survival
  Kayastha S, A N Freedman, M S Piver, Mukkamalla J, Romero-Guittierez M, Bruce A. Werness> ;Clinical Cancer Research. 1999 May 1
• 38 citations
  Paradoxical Correlations of Cyclin-dependent Kinase Inhibitors p21waf1/cip1 and p27kip1 in Metastatic Colorectal Carcinoma
  Jonathan D. Cheng, Bruce A. Werness, James Babb, Neal J. Meropol> ;Clinical Cancer Research. 1999 May 1
• 10 citations
  Trisomy 8 in stage I and stage III ovarian cancer detected by fluorescence in situ hybridization.
  Hon Fong L. Mark, Alaa M Afify, Bruce A. Werness, Sam Das, Seamus Mark, Mangala Samy> ;Experimental and Molecular Pathology. 1999 Apr 1
• Join now to see all